Janssen COVID-19 Vaccine EUA Product Leaflet

About this manual

This document provides details about Janssen's COVID-19 vaccine, including its use for preventing COVID-19 in individuals aged 18 and older. It outlines benefits, risks, side effects, and administration instructions under emergency use authorization.

The vaccine is authorized for single-dose initial vaccination and booster doses for eligible individuals. It may not protect everyone, and side effects such as injection site reactions, blood clots, or allergic reactions are possible. Users are advised to report adverse events to the FDA and CDC.

What's inside

• Who Should Receive the Vaccine
• Who Should Not Receive the Vaccine
• Vaccine Components
• How the Vaccine is Administered
• Side Effects and Risks
• Reporting Adverse Events
• Vaccine Interactions and Alternatives

Frequently asked questions

Who should receive the Janssen COVID-19 vaccine?

The vaccine is approved for emergency use in individuals aged 18 and older.

What are the risks of the Janssen COVID-19 vaccine?

Side effects may include injection site reactions, blood clots, allergic reactions, and neurological symptoms like Guillain-Barré syndrome.

How is the vaccine administered?

It is administered as a single intramuscular injection, either as an initial dose or a booster.

What should I do if I experience a severe allergic reaction?

Call 911 or go to the nearest hospital immediately.